Additional file 3: Table S3. of Patient preferences for dry powder inhaler attributes in asthma and chronic obstructive pulmonary disease in France: a discrete choice experiment

Additional file 2: of Spirometric changes during exacerbations of COPD: a post hoc analysis of the WISDOM trial

Henrik Watz (158646)
Kay Tetzlaff (805510)
Helgo Magnussen (81504)
Achim Mueller (2871755)
Roberto Rodriguez-Roisin (3498719)
Emiel Wouters (164954)
Claus Vogelmeier (340117)
Peter Calverley (3468770)

December 2018

Table S1. Baseline characteristics by treatment group for patients included in this analysis and for...

Additional file 1: Table S1. of A systematic review of comparative studies of tiotropium Respimat® and tiotropium HandiHaler® in patients with chronic obstructive pulmonary disease: does inhaler choice matter?

Ronald Dahl (3401222)
Alan Kaplan (75691)

October 2016

Including study details for all publications included in this review. (DOCX 48 kb

Additional file 6: Table S4. of Estimating prevalence of chronic obstructive pulmonary disease in the Southern Cone of Latin America: how different spirometric criteria may affect disease burden and health policies

Edgardo Sobrino (4677148)
Vilma Irazola (308006)
Laura Gutierrez (3221265)
Chung-Shiuan Chen (318759)
Fernando Lanas (3221271)
MatĂas Calandrelli (4677157)
Jacqueline Ponzo (3221253)
Nora Mores (3221277)
Pamela SerĂłn (4677151)
Allison Lee (4677154)
Jiang He (216340)
Adolfo Rubinstein (308007)

December 2017

Age-standardized Prevalence (95% Confidence Intervals) of Chronic Obstructive Pulmonary Disease in C...

Additional file 1: Table S1. of Patient preferences for dry powder inhaler attributes in asthma and chronic obstructive pulmonary disease in France: a discrete choice experiment

Natalia Hawken (4231069)
Saku Torvinen (4231075)
Mohamed-Elmoctar Neine (4231072)
Ikbel Amri (4041179)
Mondher Toumi (46017)
Samuel AballĂŠa (4231090)
Adam Plich (4231078)
Nicolas Roche (113352)

July 2017

Literature search keywords used to identify inhaler attributes in studies assessing treatment satisf...

Additional file 1: of Health status decline in Îą-1 antitrypsin deficiency: a feasible outcome for disease modifying therapies?

Robert Stockley (3450713)
Ross Edgar (5541635)
Sian Starkey (5541638)
Alice Turner (3450707)

July 2018

Table S1. Demographics of patients without COPD. Table S2. Demographics of patients with COPD. Table...

Additional file 3: Table S8. of Eligibility of real-life patients with COPD for inclusion in trials of inhaled long-acting bronchodilator therapy

David Halpin (93900)
Marjan Kerkhof (293935)
Joan Soriano (3472262)
Helga Mikkelsen (190701)
David Price (18505)

September 2016

Overview of inclusion and exclusion criteria of RCTs testing tiotropium. (XLSX 16Â kb

Additional file 2: of An attempt at modeling COPD epidemiological trends in France

Pierre-RĂŠgis Burgel (5461883)
Caroline Laurendeau (5461880)
Chantal Raherison (59830)
Claire Fuhrman (5461877)
Nicolas Roche (113352)

June 2018

2A: COPD prevalence by age, gender, and GOLD stage in the 2005 French general population. 2B: Preval...

Additional file 3: of Oxygen versus air-driven nebulisers for exacerbations of chronic obstructive pulmonary disease: a randomised controlled trial

George Bardsley (5511125)
Janine Pilcher (5816717)
Steven McKinstry (808737)
Philippa Shirtcliffe (5816723)
James Berry (3481253)
James Fingleton (3728818)
Mark Weatherall (3198705)
Richard Beasley (239695)

October 2018

Online supplement - Table S1. PtCO2 change âĽ4Â mmHg according to randomised treatment. Table S2. S...

Additional file 4: Table S9. of Eligibility of real-life patients with COPD for inclusion in trials of inhaled long-acting bronchodilator therapy

David Halpin (93900)
Marjan Kerkhof (293935)
Joan Soriano (3472262)
Helga Mikkelsen (190701)
David Price (18505)

September 2016

Overview of inclusion and exclusion criteria of RCTs testing for RCTs testing other single treatment...

Additional file 3: Table S3. of Characteristics and longitudinal progression of chronic obstructive pulmonary disease in GOLD B patients

Philip Lawrence (344694)
Umme Kolsum (3759697)
Vandana Gupta (3541757)
Gavin Donaldson (3183348)
Richa Singh (470456)
Bethan Barker (3759709)
Leena George (1656772)
Adam Webb (3759700)
Anthony Brookes (3759703)
Christopher Brightling (3759712)
Jadwiga Wedzicha (3759706)
Dave Singh (114223)

February 2017

Baseline characteristics of patients who declined to GOLD D, according to reason (FEV1 and Exacerbat...

Additional file 1: Table S1. of Genetic evaluation of the effect of GLCCI1 rs37973 on corticosteroid response in chronic obstructive pulmonary disease

Michael Mosteller (3661939)
Maarten van den Berge (116456)
Louise Hosking (3661936)
Wim Timens (41871)
Pieter Hiemstra (3661933)
Courtney Crim (164955)
Dirkje Postma (3410420)
Soumitra Ghosh (21255)

January 2017

Clinical characteristics of patients with COPD by rs37973 genotype (Studies 1 and 2). Table S2. Clin...

Additional file 2: Tables S1-S7. of Eligibility of real-life patients with COPD for inclusion in trials of inhaled long-acting bronchodilator therapy

David Halpin (93900)
Marjan Kerkhof (293935)
Joan Soriano (3472262)
Helga Mikkelsen (190701)
David Price (18505)

September 2016

Applied definitions of inclusion criteria in the Optimum Patient Care Research Database (OPCRD). Tab...

Additional file 3: of Effectiveness of a pharmacist-driven intervention in COPD (EPIC): study protocol for a randomized controlled trial

Erin Davis (3439649)
Carlo Marra (305751)
John-Michael Gamble (3454946)
Jamie Farrell (3454940)
Joe Lockyer (3454949)
J. FitzGerald (3454952)
Waseem Abu-Ashour (3454943)
Charlie Gillis (3454937)
John Hawboldt (3454955)

October 2016

COPD refresher presentation. The training presentation used to refresh participating pharmacistsâ ...

Additional file 1: of Chronic obstructive pulmonary disease, bronchial asthma and allergic rhinitis in the adult population within the commonwealth of independent states: rationale and design of the CORE study

Yuriy Feshchenko (4504408)
Liudmila Iashyna (4504420)
Damilya Nugmanova (4504402)
Olga Gyrina (4504423)
Marina Polyanskaya (4504411)
Alexander Markov (132932)
Maryna Moibenko (4504426)
Janina Makarova (4504414)
Luqman Tariq (372655)
Marcelo Pereira (3444845)
Elcan Mammadbayov (4504405)
Irada Akhundova (4504417)
Averyan Vasylyev (4504399)

October 2017

âStudy questionnaires used in the CORE studyâ contains description of the patient-reported quest...

Additional file 4: of Omega-3 fatty acid intake and prevalent respiratory symptoms among U.S. adults with COPD

Chantal Lemoine S (6730934)
Emily Brigham (6730937)
Han Woo (3408287)
Corrine Hanson (4503652)
Meredith McCormack (6730940)
Abigail Koch (6730943)
Nirupama Putcha (675426)
Nadia Hansel (4064644)

May 2019

Table S2. Stratified Characteristics of U.S. Adults with COPD, NHANES 2007â2012. (DOCX 23 kb

Additional file 2: of Spirometric changes during exacerbations of COPD: a post hoc analysis of the WISDOM trial

Henrik Watz (158646)
Kay Tetzlaff (805510)
Helgo Magnussen (81504)
Achim Mueller (2871755)
Roberto Rodriguez-Roisin (3498719)
Emiel Wouters (164954)
Claus Vogelmeier (340117)
Peter Calverley (3468770)

December 2018

Table S1. Baseline characteristics by treatment group for patients included in this analysis and for...

Additional file 1: Table S1. of A systematic review of comparative studies of tiotropium Respimat® and tiotropium HandiHaler® in patients with chronic obstructive pulmonary disease: does inhaler choice matter?

Ronald Dahl (3401222)
Alan Kaplan (75691)

October 2016

Including study details for all publications included in this review. (DOCX 48 kb

Additional file 6: Table S4. of Estimating prevalence of chronic obstructive pulmonary disease in the Southern Cone of Latin America: how different spirometric criteria may affect disease burden and health policies

Edgardo Sobrino (4677148)
Vilma Irazola (308006)
Laura Gutierrez (3221265)
Chung-Shiuan Chen (318759)
Fernando Lanas (3221271)
MatĂas Calandrelli (4677157)
Jacqueline Ponzo (3221253)
Nora Mores (3221277)
Pamela SerĂłn (4677151)
Allison Lee (4677154)
Jiang He (216340)
Adolfo Rubinstein (308007)

December 2017

Age-standardized Prevalence (95% Confidence Intervals) of Chronic Obstructive Pulmonary Disease in C...

Additional file 1: Table S1. of Patient preferences for dry powder inhaler attributes in asthma and chronic obstructive pulmonary disease in France: a discrete choice experiment

Natalia Hawken (4231069)
Saku Torvinen (4231075)
Mohamed-Elmoctar Neine (4231072)
Ikbel Amri (4041179)
Mondher Toumi (46017)
Samuel AballĂŠa (4231090)
Adam Plich (4231078)
Nicolas Roche (113352)

July 2017

Literature search keywords used to identify inhaler attributes in studies assessing treatment satisf...

Additional file 1: of Health status decline in Îą-1 antitrypsin deficiency: a feasible outcome for disease modifying therapies?

Robert Stockley (3450713)
Ross Edgar (5541635)
Sian Starkey (5541638)
Alice Turner (3450707)

July 2018

Table S1. Demographics of patients without COPD. Table S2. Demographics of patients with COPD. Table...

Additional file 3: Table S8. of Eligibility of real-life patients with COPD for inclusion in trials of inhaled long-acting bronchodilator therapy

David Halpin (93900)
Marjan Kerkhof (293935)
Joan Soriano (3472262)
Helga Mikkelsen (190701)
David Price (18505)

September 2016

Overview of inclusion and exclusion criteria of RCTs testing tiotropium. (XLSX 16Â kb

Additional file 2: of An attempt at modeling COPD epidemiological trends in France

Pierre-RĂŠgis Burgel (5461883)
Caroline Laurendeau (5461880)
Chantal Raherison (59830)
Claire Fuhrman (5461877)
Nicolas Roche (113352)

June 2018

2A: COPD prevalence by age, gender, and GOLD stage in the 2005 French general population. 2B: Preval...

Additional file 3: of Oxygen versus air-driven nebulisers for exacerbations of chronic obstructive pulmonary disease: a randomised controlled trial

George Bardsley (5511125)
Janine Pilcher (5816717)
Steven McKinstry (808737)
Philippa Shirtcliffe (5816723)
James Berry (3481253)
James Fingleton (3728818)
Mark Weatherall (3198705)
Richard Beasley (239695)

October 2018

Online supplement - Table S1. PtCO2 change âĽ4Â mmHg according to randomised treatment. Table S2. S...

Additional file 4: Table S9. of Eligibility of real-life patients with COPD for inclusion in trials of inhaled long-acting bronchodilator therapy

David Halpin (93900)
Marjan Kerkhof (293935)
Joan Soriano (3472262)
Helga Mikkelsen (190701)
David Price (18505)

September 2016

Overview of inclusion and exclusion criteria of RCTs testing for RCTs testing other single treatment...

Additional file 3: Table S3. of Characteristics and longitudinal progression of chronic obstructive pulmonary disease in GOLD B patients

Philip Lawrence (344694)
Umme Kolsum (3759697)
Vandana Gupta (3541757)
Gavin Donaldson (3183348)
Richa Singh (470456)
Bethan Barker (3759709)
Leena George (1656772)
Adam Webb (3759700)
Anthony Brookes (3759703)
Christopher Brightling (3759712)
Jadwiga Wedzicha (3759706)
Dave Singh (114223)

February 2017

Baseline characteristics of patients who declined to GOLD D, according to reason (FEV1 and Exacerbat...

Additional file 1: Table S1. of Genetic evaluation of the effect of GLCCI1 rs37973 on corticosteroid response in chronic obstructive pulmonary disease

Michael Mosteller (3661939)
Maarten van den Berge (116456)
Louise Hosking (3661936)
Wim Timens (41871)
Pieter Hiemstra (3661933)
Courtney Crim (164955)
Dirkje Postma (3410420)
Soumitra Ghosh (21255)

January 2017

Clinical characteristics of patients with COPD by rs37973 genotype (Studies 1 and 2). Table S2. Clin...

Additional file 2: Tables S1-S7. of Eligibility of real-life patients with COPD for inclusion in trials of inhaled long-acting bronchodilator therapy

David Halpin (93900)
Marjan Kerkhof (293935)
Joan Soriano (3472262)
Helga Mikkelsen (190701)
David Price (18505)

September 2016

Applied definitions of inclusion criteria in the Optimum Patient Care Research Database (OPCRD). Tab...

Additional file 3: of Effectiveness of a pharmacist-driven intervention in COPD (EPIC): study protocol for a randomized controlled trial

Erin Davis (3439649)
Carlo Marra (305751)
John-Michael Gamble (3454946)
Jamie Farrell (3454940)
Joe Lockyer (3454949)
J. FitzGerald (3454952)
Waseem Abu-Ashour (3454943)
Charlie Gillis (3454937)
John Hawboldt (3454955)

October 2016

COPD refresher presentation. The training presentation used to refresh participating pharmacistsâ ...

Additional file 1: of Chronic obstructive pulmonary disease, bronchial asthma and allergic rhinitis in the adult population within the commonwealth of independent states: rationale and design of the CORE study

Yuriy Feshchenko (4504408)
Liudmila Iashyna (4504420)
Damilya Nugmanova (4504402)
Olga Gyrina (4504423)
Marina Polyanskaya (4504411)
Alexander Markov (132932)
Maryna Moibenko (4504426)
Janina Makarova (4504414)
Luqman Tariq (372655)
Marcelo Pereira (3444845)
Elcan Mammadbayov (4504405)
Irada Akhundova (4504417)
Averyan Vasylyev (4504399)

October 2017

âStudy questionnaires used in the CORE studyâ contains description of the patient-reported quest...

Additional file 4: of Omega-3 fatty acid intake and prevalent respiratory symptoms among U.S. adults with COPD

Chantal Lemoine S (6730934)
Emily Brigham (6730937)
Han Woo (3408287)
Corrine Hanson (4503652)
Meredith McCormack (6730940)
Abigail Koch (6730943)
Nirupama Putcha (675426)
Nadia Hansel (4064644)

May 2019

Table S2. Stratified Characteristics of U.S. Adults with COPD, NHANES 2007â2012. (DOCX 23 kb

Additional file 2: of Spirometric changes during exacerbations of COPD: a post hoc analysis of the WISDOM trial

Henrik Watz (158646)
Kay Tetzlaff (805510)
Helgo Magnussen (81504)
Achim Mueller (2871755)
Roberto Rodriguez-Roisin (3498719)
Emiel Wouters (164954)
Claus Vogelmeier (340117)
Peter Calverley (3468770)

December 2018

Table S1. Baseline characteristics by treatment group for patients included in this analysis and for...

Additional file 1: Table S1. of A systematic review of comparative studies of tiotropium Respimat® and tiotropium HandiHaler® in patients with chronic obstructive pulmonary disease: does inhaler choice matter?

Ronald Dahl (3401222)
Alan Kaplan (75691)

October 2016

Including study details for all publications included in this review. (DOCX 48 kb

Additional file 6: Table S4. of Estimating prevalence of chronic obstructive pulmonary disease in the Southern Cone of Latin America: how different spirometric criteria may affect disease burden and health policies

Edgardo Sobrino (4677148)
Vilma Irazola (308006)
Laura Gutierrez (3221265)
Chung-Shiuan Chen (318759)
Fernando Lanas (3221271)
MatĂas Calandrelli (4677157)
Jacqueline Ponzo (3221253)
Nora Mores (3221277)
Pamela SerĂłn (4677151)
Allison Lee (4677154)
Jiang He (216340)
Adolfo Rubinstein (308007)

December 2017

Age-standardized Prevalence (95% Confidence Intervals) of Chronic Obstructive Pulmonary Disease in C...

Additional file 3: Table S3. of Patient preferences for dry powder inhaler attributes in asthma and chronic obstructive pulmonary disease in France: a discrete choice experiment

Abstract

Extracted data

Additional file 3: Table S3. of Patient preferences for dry powder inhaler attributes in asthma and chronic obstructive pulmonary disease in France: a discrete choice experiment

Abstract

Extracted data

Related items

Related items